We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




SonoSite Signs Definitive Agreement to Acquire VisualSonics

By HospiMedica International staff writers
Posted on 08 Jun 2010
SonoSite, Inc. More...
(Bothhell, WA, USA), a specialist in hand-carried ultrasound systems, is positioned to acquire Toronto based VisualSonics (Toronto, Canada), a company focused on ultra micro-ultrasound technology specifically designed for noninvasive preclinical research, for US$71 million.

Postmerger, the combined medical technologies of the two companies has the potential to enable expansion into new clinical markets and applications, both domestically and globally. In May 2010, SonoSite signed a deal with Physio-Control to expand their presence in the prehospital settings, and the acquisition of VisualSonics at this stage will further enable SonoSite to make inroads into preclinical settings. In addition, SonoSite will be able to leverage on VisualSonics relationships with world class pharmaceutical and biotechnology companies, universities, and medical institutions for preclinical research purposes.

Kevin M. Goodwin, SonoSite president and CEO commented on the acquisition: "Our intention is to integrate VisualSonics' micro-ultrasound technology with SonoSite's miniaturization competency and user design to deliver ultra high-frequency micro-ultrasound into clinical medicine.”

SonoSite is expected to benefit most from VisualSonics' presence in the preclinical market, which is estimated to exceed $350 million, with a projected double-digit annualized growth rate over the next few years. VisualSonics is expected to be converted into a wholly owned subsidiary of SonoSite over the next 30 days, aiding in the diversification of SonoSite's revenue base. The increase can be attributed to VisualSonics' strong product pipeline, high margin business and also a recurring revenue stream from service and accessories. The acquisition depends upon approval by VisualSonics shareholders as well as the satisfaction of other customary conditions.

Related Links:
SoniSite
VisualSonics


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Blood Bank Refrigerator
MBR-705GR-PE
Exam Table
PF400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.